, which are common in urothelial bladder carcinoma, are potentially targetable by inhibiting EZH2.
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2 | Litlas